Navigation Links
Journal of Public Health Management & Practice Calls for Growth in Public Health Workforce
Date:11/6/2009

PHILADELPHIA, Nov. 6 /PRNewswire/ -- A recent special supplement to the Journal of Public Health Management calls attention to the country's pressing need for a larger and fully capable public health workforce. The supplement, written by the leading academic voices in public health and published by Lippincott Williams & Wilkins (LWW), also sheds light on the challenges the U.S. faces in adequately meeting public health needs. LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

"There is a range of health issues that public health leaders have faced for years, including persistent racial and ethnic health disparities and chronic health challenges such as obesity and diabetes," said editor-in-chief Lloyd F. Novick, M.D., MPH. "But in the past few years, we have also struggled to accommodate emerging infectious diseases, terrorism and bioterrorism, and an escalating number of natural disasters. This supplement presents new ideas that can energize the public health field to develop solutions to the many challenges we face in building a better public health workforce."

The supplement provides a summary of the issues that have limited the growth of the public health workforce, and offers methodologies to improve research in and about the field. Supplement authors also offer insights on new strategies to recruit and inspire young people to careers in health and science.

"We have great optimism that a better understanding of the development of the public health workforce will help to build the much needed public health infrastructure for a healthier nation," said Dr. Novick. "This collection of commentary and insight can help to inspire, energize, and motivate researchers to resolve issues challenging the growth of our public health workforce."

The supplement is available for free download at www.jphmp.com and is provided courtesy of the Centers for Disease Control and Prevention.

About the Journal of Public Health Management & Practice

The Journal of Public Health Management & Practice is the leading practice-based public health journal, focused on evidence based public health practice and research. The journal publishes on a wide range of population health topics including research to practice; emergency preparedness; bioterrorism; infectious disease surveillance; environmental health; community health assessment, chronic disease prevention and health promotion, and academic-practice linkages.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.

LWW is a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons(r); and electronic information providers, such as Ovid(r), UpToDate(r), Medi-Span(r), and ProVation(r) Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of EUR3.4 billion ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.

About the CDC

The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and controlling diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes healthy living through strong partnerships with local, national, and international organizations.

Provided by Newswise, online resource for knowledge-based news at www.newswise.com

    Media Contacts:
    Natalie McGroarty
    Senior Marketing Manager
    Wolters Kluwer Health
    215-628-7759
    natalie.mcgroarty@wolterskluwer.com

    Robert Dekker
    Director of Communications
    Wolters Kluwer Health
    215-521-8928
    robert.dekker@wolterskluwer.com

SOURCE Wolters Kluwer Health: Lippincott Williams & Wilkins


'/>"/>
SOURCE Wolters Kluwer Health: Lippincott Williams & Wilkins
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: